Literature DB >> 15121811

Diagnosis and treatment of hepatitis C.

Raymond D'Souza1, Graham R Foster.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15121811      PMCID: PMC1079461          DOI: 10.1177/014107680409700504

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  22 in total

1.  The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States.

Authors:  G L Armstrong; M J Alter; G M McQuillan; H S Margolis
Journal:  Hepatology       Date:  2000-03       Impact factor: 17.425

2.  Maternal-infant transmission of hepatitis C virus and HIV infections: a possible interaction.

Authors:  M Giovannini; A Tagger; M L Ribero; G Zuccotti; L Pogliani; A Grossi; P Ferroni; A Fiocchi
Journal:  Lancet       Date:  1990-05-12       Impact factor: 79.321

3.  Hepatitis C virus and autoimmunity: fortuitous association or reality?

Authors:  F Lunel
Journal:  Gastroenterology       Date:  1994-11       Impact factor: 22.682

4.  Significance of NS3 and NS5 antigens in screening for HCV antibody.

Authors:  A M Courouce; F Bouchardeau; A Girault; N Le Marrec
Journal:  Lancet       Date:  1994-04-02       Impact factor: 79.321

Review 5.  National Institutes of Health Consensus Development Conference Panel statement: management of hepatitis C.

Authors: 
Journal:  Hepatology       Date:  1997-09       Impact factor: 17.425

6.  Sexual transmission of hepatitis C virus.

Authors:  D Bresters; E P Mauser-Bunschoten; H W Reesink; G Roosendaal; C L van der Poel; R A Chamuleau; P L Jansen; C J Weegink; H T Cuypers; P N Lelie
Journal:  Lancet       Date:  1993-07-24       Impact factor: 79.321

7.  Combination therapy with interferon plus ribavirin for the initial treatment of chronic hepatitis C.

Authors:  J G McHutchison; T Poynard
Journal:  Semin Liver Dis       Date:  1999       Impact factor: 6.115

8.  Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium.

Authors: 
Journal:  J Viral Hepat       Date:  1999-01       Impact factor: 3.728

9.  Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial.

Authors:  M P Manns; J G McHutchison; S C Gordon; V K Rustgi; M Shiffman; R Reindollar; Z D Goodman; K Koury; M Ling; J K Albrecht
Journal:  Lancet       Date:  2001-09-22       Impact factor: 79.321

10.  Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis.

Authors:  A M Di Bisceglie; Z D Goodman; K G Ishak; J H Hoofnagle; J J Melpolder; H J Alter
Journal:  Hepatology       Date:  1991-12       Impact factor: 17.425

View more
  1 in total

1.  The impact of inosine triphosphatase variants on hemoglobin level and sustained virologic response of chronic hepatitis C in Korean.

Authors:  Ju Seung Kim; Sung-Min Ahn; Young Kul Jung; Oh Sang Kwon; Yun Soo Kim; Duck Joo Choi; Ju Hyun Kim
Journal:  J Korean Med Sci       Date:  2013-07-31       Impact factor: 2.153

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.